333 related articles for article (PubMed ID: 32612071)
1. Application of Human Induced Pluripotent Stem Cell-Derived Intestinal Organoids as a Model of Epithelial Damage and Fibrosis in Inflammatory Bowel Disease.
Onozato D; Akagawa T; Kida Y; Ogawa I; Hashita T; Iwao T; Matsunaga T
Biol Pharm Bull; 2020; 43(7):1088-1095. PubMed ID: 32612071
[TBL] [Abstract][Full Text] [Related]
2. Organoid-based epithelial to mesenchymal transition (OEMT) model: from an intestinal fibrosis perspective.
Hahn S; Nam MO; Noh JH; Lee DH; Han HW; Kim DH; Hahm KB; Hong SP; Yoo JH; Yoo J
Sci Rep; 2017 May; 7(1):2435. PubMed ID: 28550311
[TBL] [Abstract][Full Text] [Related]
3. Intestinal organoids: a model of intestinal fibrosis for evaluating anti-fibrotic drugs.
Rodansky ES; Johnson LA; Huang S; Spence JR; Higgins PD
Exp Mol Pathol; 2015 Jun; 98(3):346-51. PubMed ID: 25828392
[TBL] [Abstract][Full Text] [Related]
4. Development of a Personalized Intestinal Fibrosis Model Using Human Intestinal Organoids Derived From Induced Pluripotent Stem Cells.
Estrada HQ; Patel S; Rabizadeh S; Casero D; Targan SR; Barrett RJ
Inflamm Bowel Dis; 2022 May; 28(5):667-679. PubMed ID: 34918082
[TBL] [Abstract][Full Text] [Related]
5. Intestinal enteroids/organoids: A novel platform for drug discovery in inflammatory bowel diseases.
Yoo JH; Donowitz M
World J Gastroenterol; 2019 Aug; 25(30):4125-4147. PubMed ID: 31435168
[TBL] [Abstract][Full Text] [Related]
6. Effects of human induced pluripotent stem cell-derived intestinal organoids on colitis-model mice.
Nakanishi A; Toyama S; Onozato D; Watanabe C; Hashita T; Iwao T; Matsunaga T
Regen Ther; 2022 Dec; 21():351-361. PubMed ID: 36161099
[TBL] [Abstract][Full Text] [Related]
7. Human induced pluripotent stem cell-derived mesenchymal stem cells promote healing via TNF-α-stimulated gene-6 in inflammatory bowel disease models.
Yang H; Feng R; Fu Q; Xu S; Hao X; Qiu Y; Feng T; Zeng Z; Chen M; Zhang S
Cell Death Dis; 2019 Sep; 10(10):718. PubMed ID: 31558705
[TBL] [Abstract][Full Text] [Related]
8. Ubiquitin D is Upregulated by Synergy of Notch Signalling and TNF-α in the Inflamed Intestinal Epithelia of IBD Patients.
Kawamoto A; Nagata S; Anzai S; Takahashi J; Kawai M; Hama M; Nogawa D; Yamamoto K; Kuno R; Suzuki K; Shimizu H; Hiraguri Y; Yui S; Oshima S; Tsuchiya K; Nakamura T; Ohtsuka K; Kitagawa M; Okamoto R; Watanabe M
J Crohns Colitis; 2019 Mar; 13(4):495-509. PubMed ID: 30395194
[TBL] [Abstract][Full Text] [Related]
9. Generation of Budding-Like Intestinal Organoids from Human Induced Pluripotent Stem Cells.
Onozato D; Ogawa I; Kida Y; Mizuno S; Hashita T; Iwao T; Matsunaga T
J Pharm Sci; 2021 Jul; 110(7):2637-2650. PubMed ID: 33794275
[TBL] [Abstract][Full Text] [Related]
10. Development, validation and implementation of an in vitro model for the study of metabolic and immune function in normal and inflamed human colonic epithelium.
Pedersen G
Dan Med J; 2015 Jan; 62(1):B4973. PubMed ID: 25557335
[TBL] [Abstract][Full Text] [Related]
11. Development of Physiologically Responsive Human iPSC-Derived Intestinal Epithelium to Study Barrier Dysfunction in IBD.
Gleeson JP; Estrada HQ; Yamashita M; Svendsen CN; Targan SR; Barrett RJ
Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32093254
[TBL] [Abstract][Full Text] [Related]
12. Development of a Human Intestinal Organoid Model for
Kandilogiannakis L; Filidou E; Drygiannakis I; Tarapatzi G; Didaskalou S; Koffa M; Arvanitidis K; Bamias G; Valatas V; Paspaliaris V; Kolios G
Stem Cells Int; 2021; 2021():9929461. PubMed ID: 34354753
[TBL] [Abstract][Full Text] [Related]
13. Molecular and Functional Characterization of Human Intestinal Organoids and Monolayers for Modeling Epithelial Barrier.
Jelinsky SA; Derksen M; Bauman E; Verissimo CS; van Dooremalen WTM; Roos JL; Higuera Barón C; Caballero-Franco C; Johnson BG; Rooks MG; Pott J; Oldenburg B; Vries RGJ; Boj SF; Kasaian MT; Pourfarzad F; Rosadini CV
Inflamm Bowel Dis; 2023 Feb; 29(2):195-206. PubMed ID: 36356046
[TBL] [Abstract][Full Text] [Related]
14. Generation of mesenchyme free intestinal organoids from human induced pluripotent stem cells.
Mithal A; Capilla A; Heinze D; Berical A; Villacorta-Martin C; Vedaie M; Jacob A; Abo K; Szymaniak A; Peasley M; Stuffer A; Mahoney J; Kotton DN; Hawkins F; Mostoslavsky G
Nat Commun; 2020 Jan; 11(1):215. PubMed ID: 31924806
[TBL] [Abstract][Full Text] [Related]
15. Modeling Intestinal Epithelial Response to Interferon-γ in Induced Pluripotent Stem Cell-Derived Human Intestinal Organoids.
Workman MJ; Troisi E; Targan SR; Svendsen CN; Barrett RJ
Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33396621
[TBL] [Abstract][Full Text] [Related]
16. TGF-β activation impairs fibroblast ability to support adult lung epithelial progenitor cell organoid formation.
Ng-Blichfeldt JP; de Jong T; Kortekaas RK; Wu X; Lindner M; Guryev V; Hiemstra PS; Stolk J; Königshoff M; Gosens R
Am J Physiol Lung Cell Mol Physiol; 2019 Jul; 317(1):L14-L28. PubMed ID: 30969812
[TBL] [Abstract][Full Text] [Related]
17. Cytochrome P450 expression, induction and activity in human induced pluripotent stem cell-derived intestinal organoids and comparison with primary human intestinal epithelial cells and Caco-2 cells.
Janssen AWF; Duivenvoorde LPM; Rijkers D; Nijssen R; Peijnenburg AACM; van der Zande M; Louisse J
Arch Toxicol; 2021 Mar; 95(3):907-922. PubMed ID: 33263786
[TBL] [Abstract][Full Text] [Related]
18.
Jung KB; Lee H; Son YS; Lee JH; Cho HS; Lee MO; Oh JH; Lee J; Kim S; Jung CR; Kim J; Son MY
FASEB J; 2018 Jan; 32(1):111-122. PubMed ID: 28855280
[TBL] [Abstract][Full Text] [Related]
19. [Utilization of Human iPS Cells for Evaluation of Drug Disposition and Mucosal Damages in the Small Intestine].
Iwao T
Yakugaku Zasshi; 2023; 143(3):243-247. PubMed ID: 36858557
[TBL] [Abstract][Full Text] [Related]
20. Opposite effects of interferon regulatory factor 1 and osteopontin on the apoptosis of epithelial cells induced by TNF-α in inflammatory bowel disease.
Tang R; Yang G; Zhang S; Wu C; Chen M
Inflamm Bowel Dis; 2014 Nov; 20(11):1950-61. PubMed ID: 25208103
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
